Published in Cancer Res on August 01, 2004
Imaging in the era of molecular oncology. Nature (2008) 11.10
In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. Nat Nanotechnol (2009) 3.21
In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry. Proc Natl Acad Sci U S A (2007) 2.70
In vivo, noninvasive, label-free detection and eradication of circulating metastatic melanoma cells using two-color photoacoustic flow cytometry with a diode laser. Cancer Res (2009) 2.48
Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev (2010) 2.44
In vivo multispectral, multiparameter, photoacoustic lymph flow cytometry with natural cell focusing, label-free detection and multicolor nanoparticle probes. Cytometry A (2008) 1.79
Mouse models of breast cancer metastasis. Breast Cancer Res (2006) 1.62
Portable two-color in vivo flow cytometer for real-time detection of fluorescently-labeled circulating cells. J Biomed Opt (2007) 1.46
Real-time detection of circulating apoptotic cells by in vivo flow cytometry. Mol Imaging (2005) 1.35
Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients. Int J Cancer (2010) 1.31
Nanotechnology-based molecular photoacoustic and photothermal flow cytometry platform for in-vivo detection and killing of circulating cancer stem cells. J Biophotonics (2009) 1.23
Advances in small animal mesentery models for in vivo flow cytometry, dynamic microscopy, and drug screening. World J Gastroenterol (2007) 1.18
Noninvasive imaging of flowing blood cells using label-free spectrally encoded flow cytometry. Biomed Opt Express (2012) 1.12
In vivo flow cytometry: a horizon of opportunities. Cytometry A (2011) 1.09
Multimodal In Vivo Skin Imaging with Integrated Optical Coherence and Multiphoton Microscopy. IEEE J Sel Top Quantum Electron (2012) 1.07
In vivo ultra-fast photoacoustic flow cytometry of circulating human melanoma cells using near-infrared high-pulse rate lasers. Cytometry A (2011) 1.06
Retinal flow cytometer. Opt Lett (2007) 1.02
Continual collection and re-separation of circulating tumor cells from blood using multi-stage multi-orifice flow fractionation. Biomicrofluidics (2013) 1.02
In Vivo Monitoring of Multiple Circulating Cell Populations Using Two-photon Flow Cytometry. Opt Commun (2008) 1.02
Cell labeling approaches for fluorescence-based in vivo flow cytometry. Cytometry A (2011) 0.94
Trapping and photoacoustic detection of CTCs at the single cell per milliliter level with magneto-optical coupled nanoparticles. Small (2012) 0.94
FTY720 blocks egress of T cells in part by abrogation of their adhesion on the lymph node sinus. J Immunol (2011) 0.93
Circulating Tumor Cell Detection and Capture by Photoacoustic Flow Cytometry in Vivo and ex Vivo. Cancers (Basel) (2013) 0.91
Fiber-optic multiphoton flow cytometry in whole blood and in vivo. J Biomed Opt (2010) 0.91
In vivo imaging flow cytometer. Opt Express (2006) 0.90
In vivo photoacoustic and photothermal cytometry for monitoring multiple blood rheology parameters. Cytometry A (2011) 0.90
In vivo photoswitchable flow cytometry for direct tracking of single circulating tumor cells. Chem Biol (2014) 0.87
Membrane permeable esterase-activated fluorescent imaging probe. Bioorg Med Chem Lett (2007) 0.87
Dynamic Fluctuation of Circulating Tumor Cells during Cancer Progression. Cancers (Basel) (2014) 0.85
Detection of lipid-rich prostate circulating tumour cells with coherent anti-Stokes Raman scattering microscopy. BMC Cancer (2012) 0.84
Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix. Mol Carcinog (2013) 0.83
Signal and depth enhancement for in vivo flow cytometer measurement of ear skin by optical clearing agents. Biomed Opt Express (2013) 0.83
Improved diffuse fluorescence flow cytometer prototype for high sensitivity detection of rare circulating cells in vivo. J Biomed Opt (2013) 0.82
Imaging circulating tumor cells in freely moving awake small animals using a miniaturized intravital microscope. PLoS One (2014) 0.82
In vivo multispectral photoacoustic and photothermal flow cytometry with multicolor dyes: a potential for real-time assessment of circulation, dye-cell interaction, and blood volume. Cytometry A (2011) 0.81
In vivo plant flow cytometry: a first proof-of-concept. Cytometry A (2011) 0.81
In Vivo Long-Term Monitoring of Circulating Tumor Cells Fluctuation during Medical Interventions. PLoS One (2015) 0.80
Tomographic sensing and localization of fluorescently labeled circulating cells in mice in vivo. Phys Med Biol (2012) 0.80
Nanotechnology for enrichment and detection of circulating tumor cells. Nanomedicine (Lond) (2015) 0.80
Nanomedicine: detecting rare cancer cells. Nat Nanotechnol (2009) 0.79
Multicolor multiphoton in vivo imaging flow cytometry. Opt Express (2016) 0.79
In vivo quantitation of injected circulating tumor cells from great saphenous vein based on video-rate confocal microscopy. Biomed Opt Express (2015) 0.79
Two-photon in vivo flow cytometry using a fiber probe. Proc SPIE Int Soc Opt Eng (2009) 0.77
Detection and quantitation of circulating tumor cell dynamics by bioluminescence imaging in an orthotopic mammary carcinoma model. PLoS One (2014) 0.77
Validation of a device for fluorescence sensing of rare circulating cells with diffusive light in an optical flow phantom model. Conf Proc IEEE Eng Med Biol Soc (2011) 0.75
Effect of thalidomide in combination with gemcitabine on human pancreatic carcinoma SW-1990 cell lines in vitro and in vivo. Oncol Lett (2015) 0.75
Diffuse fluorescence fiber probe for in vivo detection of circulating cells. J Biomed Opt (2017) 0.75
Performance of computer vision in vivo flow cytometry with low fluorescence contrast. J Biomed Opt (2015) 0.75
Endogenous light scattering as an optical signature of circulating tumor cell clusters. Biomed Opt Express (2016) 0.75
In vivo noninvasive microscopy of human leucocytes. Sci Rep (2017) 0.75
Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature (2008) 6.61
In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature (2005) 6.60
Chemical imaging of tissue in vivo with video-rate coherent anti-Stokes Raman scattering microscopy. Proc Natl Acad Sci U S A (2005) 5.96
Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell (2012) 4.67
Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci (2004) 4.60
Myocardial infarction accelerates atherosclerosis. Nature (2012) 4.48
Selective cell targeting with light-absorbing microparticles and nanoparticles. Biophys J (2003) 3.49
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood (2009) 3.37
Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med (2008) 2.97
Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. Blood (2007) 2.76
Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev (2010) 2.44
In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature (2011) 2.44
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features. Blood (2012) 2.35
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma. Blood (2009) 2.28
Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem Photobiol (2002) 2.18
Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle's Disease. N Engl J Med (2016) 2.15
The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia. Blood (2007) 1.99
Optical monitoring and treatment of potentially lethal wound infections in vivo. J Infect Dis (2003) 1.98
Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. J Natl Cancer Inst (2005) 1.98
Polycationic photosensitizer conjugates: effects of chain length and Gram classification on the photodynamic inactivation of bacteria. J Antimicrob Chemother (2002) 1.88
Optical properties of normal and cancerous human skin in the visible and near-infrared spectral range. J Biomed Opt (2007) 1.77
P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment. Blood (2011) 1.77
Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci Transl Med (2011) 1.75
In vivo confocal and multiphoton microendoscopy. J Biomed Opt (2008) 1.69
Detecting epidermal growth factor receptor tumor activity in vivo during cetuximab therapy of murine gliomas. Acad Radiol (2009) 1.67
Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence. JACC Cardiovasc Imaging (2012) 1.66
In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response. Nat Med (2010) 1.63
Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited. Mol Pharm (2009) 1.61
Targeted photodynamic therapy of established soft-tissue infections in mice. Photochem Photobiol Sci (2004) 1.57
In vivo quantification of tumor receptor binding potential with dual-reporter molecular imaging. Mol Imaging Biol (2012) 1.49
Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications. Clin Cancer Res (2006) 1.49
A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength. Proc Natl Acad Sci U S A (2012) 1.48
Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. J Biol Chem (2011) 1.48
Engineered vascularized bone grafts. Proc Natl Acad Sci U S A (2010) 1.47
Portable two-color in vivo flow cytometer for real-time detection of fluorescently-labeled circulating cells. J Biomed Opt (2007) 1.46
Engineered cell homing. Blood (2011) 1.43
Vascular and cellular targeting for photodynamic therapy. Crit Rev Eukaryot Gene Expr (2006) 1.41
RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma. Blood (2009) 1.39
ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth. Mol Cancer Ther (2010) 1.38
Real-time detection of circulating apoptotic cells by in vivo flow cytometry. Mol Imaging (2005) 1.35
In vivo imaging of transplanted hematopoietic stem and progenitor cells in mouse calvarium bone marrow. Nat Protoc (2010) 1.34
Differential niche and Wnt requirements during acute myeloid leukemia progression. Blood (2011) 1.32
Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria. Antimicrob Agents Chemother (2004) 1.31
Pretreatment photosensitizer dosimetry reduces variation in tumor response. Int J Radiat Oncol Biol Phys (2006) 1.31
Development and applications of photo-triggered theranostic agents. Adv Drug Deliv Rev (2010) 1.29
Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice. Photochem Photobiol Sci (2005) 1.29
Cell-surface sensors for real-time probing of cellular environments. Nat Nanotechnol (2011) 1.28
Haematopoietic stem cells depend on Galpha(s)-mediated signalling to engraft bone marrow. Nature (2009) 1.27
Strategies for enhanced photodynamic therapy effects. Photochem Photobiol (2007) 1.27
Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. Cancer Res (2010) 1.27
Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model. J Biomed Opt (2010) 1.25
Quantitative imaging of scattering changes associated with epithelial proliferation, necrosis, and fibrosis in tumors using microsampling reflectance spectroscopy. J Biomed Opt (2009) 1.23
Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules. Proc Natl Acad Sci U S A (2013) 1.23
Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT. PLoS One (2011) 1.22
Optical spectroscopy and imaging for the noninvasive evaluation of engineered tissues. Tissue Eng Part B Rev (2008) 1.20
In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment. Clin Cancer Res (2008) 1.20
Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo. Clin Cancer Res (2009) 1.20
Optical probes for biological applications based on surface-enhanced Raman scattering from indocyanine green on gold nanoparticles. Anal Chem (2005) 1.18
Imaging targeted-agent binding in vivo with two probes. J Biomed Opt (2010) 1.17
Real-time in vivo assessment of the nerve microenvironment with coherent anti-Stokes Raman scattering microscopy. Plast Reconstr Surg (2009) 1.17
Osteoblastic differentiation and stress response of human mesenchymal stem cells exposed to alternating current electric fields. Biomed Eng Online (2011) 1.16
In vivo imaging of hematopoietic stem cells and their microenvironment. J Biophotonics (2009) 1.13
A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer. Cancer Res (2006) 1.12
Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines. Lasers Surg Med (2011) 1.11
In vitro ovarian tumor growth and treatment response dynamics visualized with time-lapse OCT imaging. Opt Express (2009) 1.11
Imaging leukocyte trafficking in vivo with two-photon-excited endogenous tryptophan fluorescence. Opt Express (2010) 1.11
Defining the role of TORC1/2 in multiple myeloma. Blood (2011) 1.10
Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates. Proc Natl Acad Sci U S A (2014) 1.10
Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models. Int J Radiat Oncol Biol Phys (2010) 1.09
mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation. Blood (2013) 1.09
Photobleaching-based dosimetry predicts deposited dose in ALA-PpIX PDT of rodent esophagus. Photochem Photobiol (2007) 1.09
High vascular delivery of EGF, but low receptor binding rate is observed in AsPC-1 tumors as compared to normal pancreas. Mol Imaging Biol (2012) 1.08
Protoporphyrin IX level correlates with number of mitochondria, but increase in production correlates with tumor cell size. Photochem Photobiol (2007) 1.08
Biomodulatory approaches to photodynamic therapy for solid tumors. Cancer Lett (2012) 1.08
Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer. Cancer Res (2006) 1.07
Improved tumor contrast achieved by single time point dual-reporter fluorescence imaging. J Biomed Opt (2012) 1.07
The potential for photodynamic therapy in the treatment of localized infections. Photodiagnosis Photodyn Ther (2005) 1.06
Targeted photodynamic therapy. Lasers Surg Med (2006) 1.04
Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. Int J Radiat Oncol Biol Phys (2005) 1.03
Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy. Cancer Res (2011) 1.03
Cellular activation of the self-quenched fluorescent reporter probe in tumor microenvironment. Neoplasia (2002) 1.03
Photochemical targeting of epidermal growth factor receptor: a mechanistic study. Clin Cancer Res (2005) 1.02
Tracking mesenchymal stem cells with iron oxide nanoparticle loaded poly(lactide-co-glycolide) microparticles. Nano Lett (2012) 1.02
Imaging molecular expression on vascular endothelial cells by in vivo immunofluorescence microscopy. Mol Imaging (2006) 1.02
Ablation of leptin signaling disrupts the establishment, development, and maintenance of endometriosis-like lesions in a murine model. Endocrinology (2007) 1.02
Liposomal delivery of photosensitising agents. Expert Opin Drug Deliv (2005) 1.01
Dynamic dual-tracer MRI-guided fluorescence tomography to quantify receptor density in vivo. Proc Natl Acad Sci U S A (2013) 1.00
Three-color femtosecond source for simultaneous excitation of three fluorescent proteins in two-photon fluorescence microscopy. Biomed Opt Express (2012) 1.00
G-CSF induces E-selectin ligand expression on human myeloid cells. Nat Med (2006) 1.00
Ki-67 as a molecular target for therapy in an in vitro three-dimensional model for ovarian cancer. Cancer Res (2010) 1.00
Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier. ACS Nano (2011) 0.99
Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model. Clin Cancer Res (2005) 0.99